Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 17-(cyclobutylmethyl)morphinan-3,14-diol
2. Apo-butorphanol
3. Bc 2627
4. Bc-2627
5. Bc2627
6. Beforal
7. Butorphanol
8. Butorphanol Tartrate
9. Dolorex
10. Moradol
11. Stadol
12. Stadol Ns
13. Torbugesic
1. Butorphanol Tartrate
2. 58786-99-5
3. Butorphanol (+)-tartrate Salt
4. Stadol (tn)
5. Butorphanol Tartrate Salt
6. Butorphanol Tartrate (jan/usp)
7. Akos015994595
8. Hs-0001
9. Butorphanol (+)-tartrate Salt, >=99%
10. D00837
11. 786b995
12. Butorphanol Tartrate, United States Pharmacopeia (usp) Reference Standard
1. Butorfanol
2. Torate
3. Torbutrol
| Molecular Weight | 477.5 g/mol |
|---|---|
| Molecular Formula | C25H35NO8 |
| Hydrogen Bond Donor Count | 6 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 5 |
| Exact Mass | 477.23626707 g/mol |
| Monoisotopic Mass | 477.23626707 g/mol |
| Topological Polar Surface Area | 159 Ų |
| Heavy Atom Count | 34 |
| Formal Charge | 0 |
| Complexity | 626 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 5 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 2 | |
|---|---|
| Drug Name | Butorphanol tartrate |
| Drug Label | Butorphanol tartrate is a synthetically derived opioid agonist-antagonist analgesic of the phenanthrene series. The chemical name is (-)-17-(cyclobutylmethyl) morphinan-3, 14-diol [S-(R*,R*)] 2,3 dihydroxybutanedioate (1:1) (salt). The molecul... |
| Active Ingredient | Butorphanol tartrate |
| Dosage Form | Injectable; Spray, metered |
| Route | Nasal; Injection |
| Strength | 2mg/ml; 1mg/ml; 1mg/spray |
| Market Status | Prescription |
| Company | Bedford; Hikma Farmaceutica; Novex; Mylan; Roxane |
| 2 of 2 | |
|---|---|
| Drug Name | Butorphanol tartrate |
| Drug Label | Butorphanol tartrate is a synthetically derived opioid agonist-antagonist analgesic of the phenanthrene series. The chemical name is (-)-17-(cyclobutylmethyl) morphinan-3, 14-diol [S-(R*,R*)] 2,3 dihydroxybutanedioate (1:1) (salt). The molecul... |
| Active Ingredient | Butorphanol tartrate |
| Dosage Form | Injectable; Spray, metered |
| Route | Nasal; Injection |
| Strength | 2mg/ml; 1mg/ml; 1mg/spray |
| Market Status | Prescription |
| Company | Bedford; Hikma Farmaceutica; Novex; Mylan; Roxane |
Antitussive Agents
Agents that suppress cough. They act centrally on the medullary cough center. EXPECTORANTS, also used in the treatment of cough, act locally. (See all compounds classified as Antitussive Agents.)
Narcotics
Agents that induce NARCOSIS. Narcotics include agents that cause somnolence or induced sleep (STUPOR); natural or synthetic derivatives of OPIUM or MORPHINE or any substance that has such effects. They are potent inducers of ANALGESIA and OPIOID-RELATED DISORDERS. (See all compounds classified as Narcotics.)
Analgesics, Opioid
Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. (See all compounds classified as Analgesics, Opioid.)
Narcotic Antagonists
Agents inhibiting the effect of narcotics on the central nervous system. (See all compounds classified as Narcotic Antagonists.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Kirsch Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dr. Paul Lohmann GmbH & Co. KGaA
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Parenteral
API Stability Enhancers
Controlled & Modified Release
Thickeners and Stabilizers
Topical
Taste Masking
Solubilizers
Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
51
PharmaCompass offers a list of Butorphanol Tartrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Butorphanol Tartrate manufacturer or Butorphanol Tartrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Butorphanol Tartrate manufacturer or Butorphanol Tartrate supplier.
PharmaCompass also assists you with knowing the Butorphanol Tartrate API Price utilized in the formulation of products. Butorphanol Tartrate API Price is not always fixed or binding as the Butorphanol Tartrate Price is obtained through a variety of data sources. The Butorphanol Tartrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Beforal manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Beforal, including repackagers and relabelers. The FDA regulates Beforal manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Beforal API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Beforal manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Beforal supplier is an individual or a company that provides Beforal active pharmaceutical ingredient (API) or Beforal finished formulations upon request. The Beforal suppliers may include Beforal API manufacturers, exporters, distributors and traders.
click here to find a list of Beforal suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Beforal DMF (Drug Master File) is a document detailing the whole manufacturing process of Beforal active pharmaceutical ingredient (API) in detail. Different forms of Beforal DMFs exist exist since differing nations have different regulations, such as Beforal USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Beforal DMF submitted to regulatory agencies in the US is known as a USDMF. Beforal USDMF includes data on Beforal's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Beforal USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Beforal suppliers with USDMF on PharmaCompass.
A Beforal written confirmation (Beforal WC) is an official document issued by a regulatory agency to a Beforal manufacturer, verifying that the manufacturing facility of a Beforal active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Beforal APIs or Beforal finished pharmaceutical products to another nation, regulatory agencies frequently require a Beforal WC (written confirmation) as part of the regulatory process.
click here to find a list of Beforal suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Beforal as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Beforal API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Beforal as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Beforal and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Beforal NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Beforal suppliers with NDC on PharmaCompass.
Beforal Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Beforal GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Beforal GMP manufacturer or Beforal GMP API supplier for your needs.
A Beforal CoA (Certificate of Analysis) is a formal document that attests to Beforal's compliance with Beforal specifications and serves as a tool for batch-level quality control.
Beforal CoA mostly includes findings from lab analyses of a specific batch. For each Beforal CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Beforal may be tested according to a variety of international standards, such as European Pharmacopoeia (Beforal EP), Beforal JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Beforal USP).
